title: Atrial natriuretic peptide and fludrocortisone therapy in congenital adrenal hyperplasia.
authors.affiliation: Department of Paediatrics, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: O
authors.initials: O
authors.lastname: Arisaka
authors.forename: A
authors.initials: A
authors.lastname: Hosaka
authors.forename: M
authors.initials: M
authors.lastname: Arisaka
authors.forename: N
authors.initials: N
authors.lastname: Shimura
authors.forename: Y
authors.initials: Y
authors.lastname: Nakayama
authors.forename: Y
authors.initials: Y
authors.lastname: Yamashiro
authors.forename: K
authors.initials: K
authors.lastname: Yabuta
mesh_terms: D019326:17-alpha-Hydroxyprogesterone; D000284:Administration, Oral; D000312:Adrenal Hyperplasia, Congenital / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D000367:Age Factors; D009320:Atrial Natriuretic Factor / Q000097:blood*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005438:Fludrocortisone / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage*; D006908:Hydroxyprogesterones / Q000097:blood; D007223:Infant; D012083:Renin / Q000097:blood; D012964:Sodium / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
chemical_list: D006908:Hydroxyprogesterones; D019326:17-alpha-Hydroxyprogesterone; D009320:Atrial Natriuretic Factor; D012964:Sodium; D012083:Renin; D005438:Fludrocortisone; D006854:Hydrocortisone